Most interesting, our second-generation inhibitor, termed drug 3g, not only prevented DEPTOR/mTOR association but also induced rapid proteasomal degradation of DEPTOR, adding to the anti-MM effect (9). This evidence concerns the gene MTOR and Miyoshi myopathy.